Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
You can purchase shares of Windtree Therapeutics (NASDAQ:WINT) through any online brokerage.
Other companies in Windtree Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Qualigen Therapeutics (NASDAQ:QLGN) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
Windtree Therapeutics has a consensus price target of $1.00.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.4932 last updated November 21, 2024 at 12:26 PM EST.
There are no upcoming dividends for Windtree Therapeutics.
Windtree Therapeutics’s Q3 earnings are confirmed for Tuesday, December 3, 2024.
There is no upcoming split for Windtree Therapeutics.
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.